文献速递头颈CT

头颈癌放疗计划中与专科放射科医生联合同行评审的定量影响

The quantitative impact of joint peer review with a specialist radiologist in head and neck cancer radiotherapy planning.
PubMed 文献 · Br J Radiol · 2021-12-21

本研究对2020年8月至11月接受根治剂量放疗的头颈癌患者进行前瞻性记录,评估放射科医生参与同行评审的常规科室做法,采用Jaccard指数、地理遗漏指数和豪斯多夫距离定量分析放疗体积修正。87例中73例(84%)被讨论,38例(52%)建议修改,其中30例有至少1项重大修改、8例仅有轻微修改;结论认为该做法可行且有助于避免勾画重大错误。

要点

  • 放射科医生参与头颈放疗同行评审,52%(38/73)患者建议修改体积,其中30例有重大修改。
  • 淋巴结大体肿瘤体积和治疗性高剂量淋巴结临床靶区体积修改幅度最大。
  • 85个「重大」修改与14个「轻微」修改体积的定量指标未见差异(p=0.5)。

核心结论

  • 常规头颈放射科医生参与放疗同行评审是可行的,可能有助于避免勾画中的重大错误。

研究设计与样本

  • 前瞻性记录2020年8月至11月接受根治剂量放疗的头颈癌患者,评估放射科医生参与同行评审的科室常规做法。
  • 共87例患者中73例(84%)被讨论,修改依据皇家放射科学院(Royal College of Radiologists)指南定义重大和轻微修改。
  • 采用Jaccard指数评估 conformity、地理遗漏指数评估 undercontouring、豪斯多夫距离评估体积间距离。

诊断标准与关键数值

  • 38例(52%)患者建议修改:30例有至少1项重大修改,8例仅有轻微修改。
  • 99个修正体积总体中位Jaccard指数0.91(IQR=0.80-0.97)、地理遗漏指数0.06(IQR=0.02-0.18)、豪斯多夫距离0.42 cm(IQR=0.20-1.17 cm)。
  • 淋巴结大体肿瘤体积(GTVn)中位Jaccard指数0.89(IQR=0.44-0.95)、地理遗漏指数0.11(IQR=0.05-0.51)、豪斯多夫距离3.71 cm(IQR=0.31-6.93 cm)。
  • 治疗性高剂量淋巴结临床靶区体积(CTVn)中位Jaccard指数0.78(IQR=0.59-0.90)、地理遗漏指数0.20(IQR=0.07-0.31)、豪斯多夫距离3.28 cm(IQR=1.22-6.18 cm)。
  • 85个「重大」修改与14个「轻微」修改体积的定量指标未见差异(p=0.5)。

临床应用与阅片要点

  • 作者认为常规头颈放射科医生参与放疗同行评审是可行的,可能有助于避免勾画中的重大错误。
  • 作者指出重大和轻微分类可能受益于定量指标的区分,但需要与临床结局进行相关性分析。

局限性

  • 重大和轻微分类可能受益于定量指标的区分,但需要与临床结局进行相关性分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Radiologist input in peer review of head and neck radiotherapy has been introduced as a routine departmental approach. The aim was to evaluate this practice and to quantitatively analyse the changes made.

METHODS: Patients treated with radical-dose radiotherapy between August and November 2020 were reviewed. The incidence of major and minor changes, as defined by The Royal College of Radiologists guidance, was prospectively recorded. The amended radiotherapy volumes were compared with the original volumes using Jaccard Index (JI) to assess conformity; Geographical Miss Index (GMI) for undercontouring; and Hausdorff Distance (HD) between the volumes.

RESULTS: In total, 73 out of 87 (84%) patients were discussed. Changes were recommended in 38 (52%) patients: 30 had ≥1 major change, eight had minor changes only. There were 99 amended volumes: The overall median JI, GMI and HD was 0.91 (interquartile range [IQR]=0.80-0.97), 0.06 (IQR = 0.02-0.18) and 0.42 cm (IQR = 0.20-1.17 cm), respectively. The nodal gross-tumour-volume (GTVn) and therapeutic high-dose nodal clinical-target-volume (CTVn) had the biggest magnitude of changes: The median JI, GMI and HD of GTVn was 0.89 (IQR = 0.44-0.95), 0.11 (IQR = 0.05-0.51), 3.71 cm (IQR = 0.31-6.93 cm); high-dose CTVn was 0.78 (IQR = 0.59-0.90), 0.20 (IQR = 0.07-0.31) and 3.28 cm (IQR = 1.22-6.18 cm), respectively. There was no observed difference in the quantitative indices of the 85 'major' and 14 'minor' volumes (p = 0.5).

CONCLUSIONS: Routine head and neck radiologist input in radiotherapy peer review is feasible and can help avoid gross error in contouring.

ADVANCES IN KNOWLEDGE: The major and minor classifications may benefit from differentiation with quantitative indices but requires correlation from clinical outcomes.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Chiu, Hoskin, Gupta, et al. The quantitative impact of joint peer review with a specialist radiologist in head and neck cancer radiotherapy planning. Br J Radiol. 2021. PMID: 34918547. doi:10.1259/bjr.20211219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。